Navigation Links
KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody
Date:12/10/2013

unogenicity and clinical activity. The investigators also evaluated EphA3 expression on tumor, stromal and endothelial cells.

Nestor Molfino, M.D., MSc, KaloBios' Chief Medical Officer, commented, "KB004 targets EphA3, which is expressed in adults on hematologic malignancies and solid tumors, including tumor stem cells, but not on normal blood or bone marrow stem cells. The targeted nature of this antibody may represent a promising approach to selectively treat patients with hematologic malignancies. As we have not yet reached a maximum tolerated dose, we will continue to study higher doses of KB004 as part of this ongoing trial to determine an optimum high-end dose for the Phase 2 expansion portion of the study in patients with AML or myelodysplastic syndrome (MDS) which is expected to begin by the end of the year."

The poster presented at ASH can be viewed on the KaloBios website.

About KaloBios

KaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies designed to treat severe life-threatening or debilitating diseases for which there is an unmet medical need, with a clinical focus on severe respiratory diseases and cancer.

Currently, KaloBios has three drug development programs:

  • KB003, an anti-GM-CSF mAb with potential to treat inflammatory diseases, being developed for the treatment of severe asthma. Enrollment of 160 patients has been completed in a Phase 2 study in the United States, Europe and Australia.
  • KB001-A, an anti-PcrV mAb fragment, partnered exclusively with Sanofi Pasteur and is being developed for the pr
    '/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH
2. Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors
3. Reproductive Health Matters announces publication of its latest themed issue: New development paradigm
4. Afterburn Fuel Review Announces the Launch of its New and Informative Website
5. VaxTrac Announces Continued Support for Expansion of Biometric-based Mobile Vaccine Registry Programs in Benin
6. AIBS announces winners of Faces of Biology photo competition
7. NERC announces the winner of its first photo and essay competition
8. Elsevier announces the launch of open access journal: Current Plant Biology
9. AVS Announces Its Major Award Winners of 2013
10. The Association for Molecular Pathology announces highlights of Phoenix meeting
11. EMBO announces the launch of EMBO Press
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... ... Technology, TUSTIN, Calif., ... with isochronous data transfer,support. The SX-2000WG+ allows streaming video and audio ... Windows and,Macintosh users over an 802.11b/g wireless network or an Ethernet ...
... rocks and cause anglers to slip while fly fishing contain oil ... University microbiologist. Drivers can,t pump algal fuel into their gas ... He felt that way 20 years ago. He feels that way ... been so short-sighted," Cooksey said. Cooksey is one of many ...
... headed by an environmental engineer at Washington University in St. ... ethanol. , The ... plant biomass parts that range from woody stems, straw, agricultural residues, ... some lignin. , ...
Cached Biology News:Silex Introduces World's First Wireless USB Device Server With Streaming Video and Audio Data Transfer 2Montana State University researcher finds renewed interest in turning algae into fuel 2Montana State University researcher finds renewed interest in turning algae into fuel 3New techniques create butanol 2
(Date:8/3/2015)... Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... on the development of autologous cell therapies, announced today that ... the InvestMNT conference held in Minneapolis, Minnesota ... time. Hall,s presentation will highlight RepliCel,s 18-month milestones including CE ... Europe , clinical data from both RCT-01 (tendon) ...
(Date:7/31/2015)... ... 31, 2015 , ... Global Resorcinol Market 2015-2019 is a ... the global resorcinol industry. The report highlights the various growth prospects and the ... analysis of primary and secondary inputs from the existing players of the resorcinol ...
(Date:7/30/2015)... , ... July 31, 2015 , ... Ralco is honored ... at the Lyon County Fair to be held August 5-9 in Marshall. The Ralco ... their meals come from and how agriculture impacts their daily lives. This unique exhibit ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Vieillard as Sales & Marketing Director. , With more than 25 years ... responsible for reinforcing Tronics’ business development activities worldwide. He brings to the company ...
Breaking Biology Technology:RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2
... Development of Gene Expression Signatures Derived by COXEN ... Molecular Test of Responsiveness to Current Treatments, ... Transgenomic (OTC Bulletin Board: TBIO) today announced a ... test which will guide,clinicians in their choice of ...
... Intact Medical Corporation, an,emerging leader in the development ... and removal of breast lesions, today announced,that it ... 510(k),clearance for the Intact (R) Excise XL - ... wands, used with the Intact (R) Breast Lesion ...
... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) announced today ... its lead product candidate for the treatment of ... mitogen-activated ERK kinase,(MEK) inhibitor for the treatment of ... College of American College of Rheumatology,(ACR) / Association ...
Cached Biology Technology:Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options 2Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options 3Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options 4Intact Medical Corporation's Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA 2Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting 2Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting 3
... This CLS number is ... created to easily match ... showing no availability yet, ... old Sigma-Aldrich number (Z71,448-8) ...
... Adept CE 4100 high pressure dual piston ... one microlitre increaments. The ground breaking ... flexibility. The WaveQuest provides a ... and provides superior stability . Hence ...
... of large numbers of samples may be carried ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied detector ...
...
Biology Products: